Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krusius

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
BMC Medical Genetics|January 22, 2005
Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertensionTuula Hannila-Handelberg, Kimmo Kontula, Ilkka Tikkanen, et al.
Transfusion|June 10, 2010
Female donors and transfusion-related acute lung injury: A case-referent study from the International TRALI Unisex Research GroupRutger A Middelburg, Daniëlle Van Stein, Barbara Zupanska, et al.
Vox Sanguinis|August 16, 2006
Development of permanent national register of blood component use utilizing electronic hospital information systemsR Palo, T Ali-Melkkilä, R Hanhela, et al.
Vox Sanguinis|August 6, 1998
Consequences of nucleic acid amplification testing for blood transfusion centresH W Reesink, C P Engelfriet, H Vrielink, et al.
Vox Sanguinis|April 24, 2012
Prion reduction of red-blood-cellsJ Coste, C Prowse, C Grabmer, et al.
Vox Sanguinis|July 9, 2002
Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?H W Reesink, C P Engelfriet, G E Tegtmeier, et al.
Vox Sanguinis|November 30, 1999
Haemovigilance systemsC P Engelfriet, H W Reesink, B Brand, et al.
Vox Sanguinis|June 26, 2003
The future use of pathogen-inactivated platelet concentratesC P Engelfriet, H W Reesink, H G Klein, et al.
Vox Sanguinis|August 20, 2003
Future counselling of donors and recipients of blood products concerning prion-related diseasesH W Reesink, C P Engelfriet, L Muylle, et al.
Vox Sanguinis|April 28, 2009
New cellular therapies: is there a role for transfusion services?H W Reesink, S Panzer, M Dettke, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
BMC Medical Genetics|January 22, 2005
Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertensionTuula Hannila-Handelberg, Kimmo Kontula, Ilkka Tikkanen, et al.
Transfusion|June 10, 2010
Female donors and transfusion-related acute lung injury: A case-referent study from the International TRALI Unisex Research GroupRutger A Middelburg, Daniëlle Van Stein, Barbara Zupanska, et al.
Vox Sanguinis|August 16, 2006
Development of permanent national register of blood component use utilizing electronic hospital information systemsR Palo, T Ali-Melkkilä, R Hanhela, et al.
Vox Sanguinis|August 6, 1998
Consequences of nucleic acid amplification testing for blood transfusion centresH W Reesink, C P Engelfriet, H Vrielink, et al.
Vox Sanguinis|April 24, 2012
Prion reduction of red-blood-cellsJ Coste, C Prowse, C Grabmer, et al.
Vox Sanguinis|July 9, 2002
Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?H W Reesink, C P Engelfriet, G E Tegtmeier, et al.
Vox Sanguinis|November 30, 1999
Haemovigilance systemsC P Engelfriet, H W Reesink, B Brand, et al.
Vox Sanguinis|June 26, 2003
The future use of pathogen-inactivated platelet concentratesC P Engelfriet, H W Reesink, H G Klein, et al.
Vox Sanguinis|August 20, 2003
Future counselling of donors and recipients of blood products concerning prion-related diseasesH W Reesink, C P Engelfriet, L Muylle, et al.
Vox Sanguinis|April 28, 2009
New cellular therapies: is there a role for transfusion services?H W Reesink, S Panzer, M Dettke, et al.
Pageof 15